AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TEMPEST MINERALS LTD

0.006

0.000

Volume:260.01K

Turnover:1.56K

Market Cap:6.61M

PE:-2.50

High:0.006

Open:0.006

Low:0.006

Close:0.006

52wk High:0.012

52wk Low:0.003

Shares:1.10B

Float Shares:783.81M

Volume Ratio:0.07

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.002

EPS(LYR):-0.002

ROE:-14.27%

ROA:-9.89%

PB:0.58

PE(LYR):-2.50

Loading ...

Overview Company News Filings

Capricorn Metals Completes Acquisition of Western Australia Project from Tempest Minerals for AU$4.5 Million Consideration

MT Newswires Live

Capricorn Metals to Acquire Western Australia Tenements From Tempest Minerals

MT Newswires Live

Capricorn Metals Ltd-Capricorn Metals Limited to Acquire Yalgoo Project,Cmm

THOMSON REUTERS

Tempest Minerals Ltd-Option Agreement With Green Steel to Acquire Remorse Project

THOMSON REUTERS

Tempus AI (TEM): Assessing Valuation Following Analyst Optimism on Growth Drivers and Precision Medicine Collaboration

Simply Wall St.

How Investors Are Reacting To Tempus AI (TEM) Raising Guidance on Strong Sales and Margin Momentum

Simply Wall St.

Tempus AI (TEM): Assessing Valuation After FDA Approvals and Whitehawk Therapeutics Partnership

Simply Wall St.

ASX Small-Cap Stocks to Watch

MT Newswires Live

Whitehawk Shares Rise After Forming Collaboration With Tempus AI to Advance Oncology Research

MT Newswires Live

Why Tempus AI (TEM) Is Up 11.2% After Securing ARPA-H Precision Cancer Therapy Collaboration

Simply Wall St.

Tempest Minerals Starts Reverse Circulation Drilling at Western Australia Project

MT Newswires Live

ASX Small-Cap Stocks to Watch

MT Newswires Live

Tempest Minerals Receives Drilling Approval for Western Australia Prospect; Shares Jump 13%

MT Newswires Live

Tempus AI Teams Up With Renalytix to Boost Adoption of Prognostic Blood Test for Kidney Disease

MT Newswires Live

Tempus AI (TEM) Is Up 8.5% After FDA Clearance for Advanced Cardiac MRI Mapping – Has the Bull Case Changed?

Simply Wall St.

Tempus AI Buys Paige

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TEM.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TEM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TEM.AU\",,,,,undefined,":{"symbol":"TEM.AU","market":"AU","secType":"STK","nameCN":"TEMPEST MINERALS LTD","latestPrice":0.006,"timestamp":1772082720000,"preClose":0.006,"halted":0,"volume":260006,"delay":0,"changeRate":0,"nameEN":"TEMPEST MINERALS LTD","floatShares":783809500,"shares":1101876292,"eps":-0.002399,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-26 16:12:00 AEDT","open":0.006,"high":0.006,"low":0.006,"amount":1560,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.002399,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772146800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.006,"openAndCloseTimeList":[[1772060400000,1772082000000]],"volumeRatio":0.06574858473314904,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TEM.AU\",,,,,undefined,":{"symbol":"TEM.AU","floatShares":783809500,"roa":"-9.89%","roe":"-14.27%","lyrEps":-0.002399,"volumeRatio":0.06574858473314904,"shares":1101876292,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.006,"low":0.006,"week52Low":0.003,"pbRate":"0.58","psRate":"146.67","week52High":0.012,"institutionHeld":0,"latestPrice":0.006,"eps":-0.002399,"divideRate":0,"volume":260006,"delay":0,"ttmEps":-0.002399,"open":0.006,"prevYearClose":0.007,"prevWeekClose":0.006,"prevMonthClose":0.007,"prevQuarterClose":0.007,"fiveDayClose":0.006,"twentyDayClose":0.007,"sixtyDayClose":0.007,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TEM.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-06-04","symbol":"TEM.AU","defaultRemindTime":1717459200000,"type":"split","dateTimestamp":1717423200000,"forFactor":954545,"toFactor":1000000,"ratio":0.954545}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TEM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TEM.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611345170","title":"Capricorn Metals Completes Acquisition of Western Australia Project from Tempest Minerals for AU$4.5 Million Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2611345170","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611345170?lang=en_us&edition=fundamental","pubTime":"2026-02-16 11:00","pubTimestamp":1771210853,"startTime":"0","endTime":"0","summary":"Capricorn Metals  completed the acquisition of the Yalgoo project in Western Australia from Tempest Minerals  for a consideration of AU$4.5 million, according to a Monday Australian bourse filing.Capricorn paid an initial cash deposit of AU$100,000 in December 2025, and on settlement, it paid another AU$400,000 in cash and issued 294,811 Capricorn shares to Tempest Minerals.Capricorn also agreed to make contingent payments of AU$750,000 in cash upon the announcement of a mineral resource estimate of over 75,000 ounces of gold on the project, as well as another AU$750,000 in cash upon the announcement of a board decision to commence a commercial mining operation on the project.Tempest retained ownership of the iron mineralization-bearing eastern tenements, which host both the Remorse deposit and the Halo target.Capricorn's shares rose 2% in recent trading on Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4109","BK7104","XKO.AU","WRN","TEM.AU","BK4168","XAO.AU","MTX","XJO.AU","CMM.AU","BK7095"],"gpt_icon":0},{"id":"2593745615","title":"Capricorn Metals to Acquire Western Australia Tenements From Tempest Minerals","url":"https://stock-news.laohu8.com/highlight/detail?id=2593745615","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593745615?lang=en_us&edition=fundamental","pubTime":"2025-12-23 07:21","pubTimestamp":1766445681,"startTime":"0","endTime":"0","summary":"Capricorn Metals  agreed to acquire the Yalgoo project tenement package in Western Australia from Tempest Minerals  for AU$4.5 million, according to a Tuesday filing with the Australian bourse.The consideration comprises an initial deposit of AU$100,000 in cash, AU$400,000 in cash upon completion, as well as the issue of shares in the company worth AU$4 million, the filing said.The transaction is expected to be completed in January 2026, per the filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WRN","BK7104","CMM.AU","XJO.AU","MTX","TEM.AU","XAO.AU","XKO.AU","BK4109","BK4168","BK7095"],"gpt_icon":0},{"id":"2593645873","title":"Capricorn Metals Ltd-Capricorn Metals Limited to Acquire Yalgoo Project,Cmm","url":"https://stock-news.laohu8.com/highlight/detail?id=2593645873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593645873?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:31","pubTimestamp":1766439069,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUE3PKLNP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7104","CMM.AU","BK7095","TEM.AU"],"gpt_icon":0},{"id":"2590632437","title":"Tempest Minerals Ltd-Option Agreement With Green Steel to Acquire Remorse Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2590632437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590632437?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:21","pubTimestamp":1765315304,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUE5HJDWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","TEM.AU"],"gpt_icon":0},{"id":"2587676555","title":"Tempus AI (TEM): Assessing Valuation Following Analyst Optimism on Growth Drivers and Precision Medicine Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2587676555","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587676555?lang=en_us&edition=fundamental","pubTime":"2025-11-29 20:23","pubTimestamp":1764418996,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) is drawing new attention after analysts highlighted strong momentum from its Ambry acquisition, advances in rare disease testing, and a new collaboration focused on precision medicine. Investors are watching closely as these factors develop.\nSee our latest analysis for Tempus AI.\nTempus AI’s share price has surged more than 127% year to date as interest in healthcare innovation grows, even with some volatility along the way. Recent momentum from its Ambry acquisition and new...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-assessing-valuation-following-analyst-optimism","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-assessing-valuation-following-analyst-optimism","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1861558580.USD","TEM","BK4121","BK4528","AI","TEM.AU","BK4611","BK4587","BK4551","BK4588","BK4613","LU1861559042.SGD","BK7095","BK4023","BK4585","BK4543"],"gpt_icon":1},{"id":"2580476054","title":"How Investors Are Reacting To Tempus AI (TEM) Raising Guidance on Strong Sales and Margin Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2580476054","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580476054?lang=en_us&edition=fundamental","pubTime":"2025-11-02 01:35","pubTimestamp":1762018519,"startTime":"0","endTime":"0","summary":"Tempus AI recently announced strong quarterly results and raised its full-year guidance, highlighting robust sales and margin growth across its AI-enabled precision medicine business.\nThese developments underscore growing adoption of Tempus AI's technology and successful execution of acquisitions, supporting optimistic analyst outlooks for future company expansion.\nWe'll explore how Tempus AI's raised guidance and accelerated growth momentum impact its investment narrative in the evolving...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/how-investors-are-reacting-to-tempus-ai-tem-raising-guidance","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/how-investors-are-reacting-to-tempus-ai-tem-raising-guidance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TEM","ISBC","TEM.AU"],"gpt_icon":1},{"id":"2578698110","title":"Tempus AI (TEM): Assessing Valuation After FDA Approvals and Whitehawk Therapeutics Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2578698110","media":"Simply Wall St.","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578698110?lang=en_us&edition=fundamental","pubTime":"2025-10-28 13:28","pubTimestamp":1761629338,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has been busy lately, securing several FDA 510(k) clearances for its AI-powered diagnostic platforms and revealing a multi-year research partnership with Whitehawk Therapeutics. These moves are attracting fresh attention from the market.\nSee our latest analysis for Tempus AI.\nTempus AI’s recent FDA clearances and its new partnership with Whitehawk Therapeutics have fueled strong momentum, with the stock notching a 57% gain in its 90-day share price return and an impressive...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-assessing-valuation-after-fda-approvals-and-wh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-assessing-valuation-after-fda-approvals-and-wh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","LU1861558580.USD","BK4611","TEM.AU","AI","DCF","BK4613","BK4551","BK4585","BK4587","BK4139","BK4007","BK4023","BK4539","BK4528","LENZ","BK7095","BK4588","LU1861559042.SGD","BK4543"],"gpt_icon":1},{"id":"2576004777","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2576004777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576004777?lang=en_us&edition=fundamental","pubTime":"2025-10-20 07:43","pubTimestamp":1760917386,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Infini Resources (ASX:I88)Infini Resources will undertake a follow-up field program a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GA8.AU","BK7057","XAO.AU","AQN.AU","XKO.AU","TEM.AU","XJO.AU","BK7095","BK7104","I88.AU","AUV.AU"],"gpt_icon":0},{"id":"2575744129","title":"Whitehawk Shares Rise After Forming Collaboration With Tempus AI to Advance Oncology Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2575744129","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575744129?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:32","pubTimestamp":1760621574,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics  shares were sharply higher Thursday after the company formed a multi-year collaboration with Tempus AI  to leverage Tempus' real-world dataset to advance biomarker-driven research and further Whitehawk Therapeutics' oncology pipeline, Tempus said.The collaboration will focus on Whitehawk Therapeutics' antibody drug conjugates portfolio, which includes three assets designed to target proteins that are broadly expressed in high-potential cancer indications, such as lung and gynecological cancers, the company said.Shares of Tempus AI and Whitehawk were up 5.3% and 54.7%, respectively, in early trading.Price: 3.28, Change: +1.17, Percent Change: +55.45","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","BK4613","LU1861558580.USD","LU1861559042.SGD","TEM","BK7095","TEM.AU","WHWK","BK4611","BK4139"],"gpt_icon":1},{"id":"2574485960","title":"Why Tempus AI (TEM) Is Up 11.2% After Securing ARPA-H Precision Cancer Therapy Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2574485960","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574485960?lang=en_us&edition=fundamental","pubTime":"2025-10-11 02:23","pubTimestamp":1760120599,"startTime":"0","endTime":"0","summary":"Tempus AI, Inc. announced it has been selected by the U.S. Department of Health and Human Services' Advanced Research Projects Agency for Health (ARPA-H) to provide AI-enabled diagnostics and contract research services for the ADAPT precision cancer therapy program targeting metastatic lung, breast, and colorectal cancers.\nThe collaboration not only highlights Tempus AI's pivotal role in government-backed precision medicine initiatives but also showcases its multi-omics capabilities and data...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/why-tempus-ai-tem-is-up-112-after-securing-arpa-h-precision","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/why-tempus-ai-tem-is-up-112-after-securing-arpa-h-precision","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4023","BK4121","BK4587","BK4585","BK4543","BK4528","LU1861558580.USD","TEM","BK4588","BK4611","BK4613","TEM.AU","LU1861559042.SGD","BK4551","BK7095"],"gpt_icon":1},{"id":"2571877267","title":"Tempest Minerals Starts Reverse Circulation Drilling at Western Australia Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2571877267","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571877267?lang=en_us&edition=fundamental","pubTime":"2025-09-29 11:39","pubTimestamp":1759117144,"startTime":"0","endTime":"0","summary":"Tempest Minerals  started a reverse circulation drilling program at its Range project in Western Australia, according to a Monday filing with the Australian bourse.The program is designed to target high-priority gold targets, including those with gold rock chips discovered at the surface, the filing said.Meanwhile, an auger sampling program on the south side of the project is underway, per the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4109","BK7095","WRN","TEM.AU","XAO.AU","XKO.AU","XJO.AU","BK4168","MTX"],"gpt_icon":0},{"id":"2570034899","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2570034899","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570034899?lang=en_us&edition=fundamental","pubTime":"2025-09-25 07:48","pubTimestamp":1758757685,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Morella Morella secured the Dixon Well project in Western Australia as it expands its portfolio into titanium. An initial site visit confirmed the presence of titanium mineralization in quartz-ilmenite veins, with rock chip assays yielding grades of up to 17% titanium oxide.Lefroy Exploration Lefroy Exploration received high-grade gold assays across the Lucky Strike project in Western Australia, supporting the potential for an expanded second stage pit shell design.BPH Energy BPH Energy said the originating application in relation to the PEP 11 joint venture with Bounty Oil and Gas  is listed for a two-day hearing on Feb. 20 and 23, 2026.Platina Resources Platina Resources will conduct exploration activities at its Mt McKenna gold project in Western Australia after receiving cultural heritage clearance from the traditional owners. Drilling is expected to begin in November.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","BK7116","1MC.AU","BK7142","BK7504","PGM.AU","TEM.AU","LEX.AU","XKO.AU","XAO.AU","XJO.AU","BK7048","BPH.AU","BUY.AU","BK7062"],"gpt_icon":0},{"id":"2568044735","title":"Tempest Minerals Receives Drilling Approval for Western Australia Prospect; Shares Jump 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568044735","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568044735?lang=en_us&edition=fundamental","pubTime":"2025-09-18 11:08","pubTimestamp":1758164923,"startTime":"0","endTime":"0","summary":"Tempest Minerals  received regulatory approval to drill at the Halo prospect at the Yalgoo project in Western Australia, according to a Thursday Australian bourse filing.The firm is working closely with the traditional owners of the area in completing a heritage survey of the drilling program target.Tempest Minerals' shares jumped almost 13% in recent trading on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEM.AU","XAO.AU","XKO.AU","WRN","XJO.AU","BK7095","BK4168","BK4109","MTX"],"gpt_icon":0},{"id":"2567149401","title":"Tempus AI Teams Up With Renalytix to Boost Adoption of Prognostic Blood Test for Kidney Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2567149401","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567149401?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:52","pubTimestamp":1757940745,"startTime":"0","endTime":"0","summary":"Tempus AI  has formed a partnership with Renalytix to boost adoption of the kidneyintelX.dkd prognostic blood test for eligible patients who have type 2 diabetes with chronic kidney disease, Renalytix said Monday.Renalytix said its kidneyintelX.dkd will be the first chronic kidney disease test in Tempus' portfolio, designed for use in risk prediction for progressive kidney function decline in type 2 diabetes patients with chronic kidney disease stages 1-3b.The tests will be processed at a Renalytix laboratory and the tests' insights will be used for making changes in patient management, potentially helping healthcare providers improve key metrics in diabetes and kidney care and mitigate kidney function decline, the company said.Tempus AI shares were up nearly 2% in recent premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEM.AU","BK4611","LU1861558580.USD","BK4613","TEM","LU1861559042.SGD","BK7095","BK4121"],"gpt_icon":1},{"id":"2567915021","title":"Tempus AI (TEM) Is Up 8.5% After FDA Clearance for Advanced Cardiac MRI Mapping – Has the Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2567915021","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567915021?lang=en_us&edition=fundamental","pubTime":"2025-09-15 00:25","pubTimestamp":1757867101,"startTime":"0","endTime":"0","summary":"Tempus AI recently received FDA 510(k) clearance for its updated Tempus Pixel platform, enabling T1 and T2 inline mapping for enhanced cardiac MR image analysis using artificial intelligence.\nThis advancement allows clinicians to generate precise, quantitative tissue assessments directly from raw MRI data, providing new diagnostic capabilities even on scanners without native mapping support.\nWe'll explore how this recent regulatory milestone and Tempus Pixel's expanded functionality could...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-is-up-85-after-fda-clearance-for-advanced-card","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-is-up-85-after-fda-clearance-for-advanced-card","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","TEM","BK6522","BLZ.SI","IE00B19Z4B17.USD","AEIS","IE00B66KJ199.SGD","LU1861558580.USD","LU1861559042.SGD","BK4611","TEM.AU","BK7095","BK4157","IE00B7SZL793.SGD","BK4613","IE0031619046.USD","BK6088"],"gpt_icon":1},{"id":"2561477085","title":"Tempus AI Buys Paige","url":"https://stock-news.laohu8.com/highlight/detail?id=2561477085","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561477085?lang=en_us&edition=fundamental","pubTime":"2025-08-22 21:38","pubTimestamp":1755869926,"startTime":"0","endTime":"0","summary":"Tempus AI  said Friday it is acquiring artificial intelligence company Paige for roughly $81.3 million.The amount is being paid mostly in Tempus shares, along with Tempus AI's assumption of Paige's remaining commitment under a Microsoft  Azure cloud services deal, the company said.Price: 76.21, Change: -0.50, Percent Change: -0.66","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEM","LU1670628061.USD","IE00BJJMRX11.SGD","LU2286300806.USD","LU1340139317.AUD","LU0738911758.USD","LU2362540622.SGD","LU2746668974.SGD","LU1778281490.HKD","LU2168564065.EUR","IE00B7KXQ091.USD","SG9999015341.SGD","LU1582986359.USD","LU2750360997.AUD","LU0965509283.SGD","LU0784383803.USD","LU1989764748.USD","LU2403377893.USD","LU0965509010.AUD","LU1496350502.SGD","IE00BMPRXR70.SGD","LU1732800096.USD","LU2543165471.USD","LU1316542783.SGD","LU1582987597.SGD","LU1066051498.USD","LU0345768740.USD","LU2552382215.SGD","IE00BDCRKT87.USD","LU2362541513.USD","LU1721428933.USD","LU1629891620.HKD","LU0056508442.USD","LU1989773731.SGD","BK4611","LU1623119135.USD","LU0964807845.USD","LU0949170426.SGD","LU1066051225.USD","IE000KEQY171.SGD","IE00BYQQ9H92.USD","IE00BLSP4239.USD","LU0203202063.USD","BK4579","LU1674673691.USD","LU1670710661.SGD","TEM.AU","LU2430703178.SGD","LU0310799852.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}